These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT. Biol Psychiatry; 2007 Dec 15; 62(12):1371-9. PubMed ID: 17825800 [Abstract] [Full Text] [Related]
10. Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder. Vittengl JR, Clark LA, Thase ME, Jarrett RB. J Affect Disord; 2016 Jul 15; 199():148-56. PubMed ID: 27104803 [Abstract] [Full Text] [Related]
15. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, Jones JM, Tao R, Stewart SM, Jarrett RB. J Am Acad Child Adolesc Psychiatry; 2008 Dec 15; 47(12):1395-404. PubMed ID: 18978634 [Abstract] [Full Text] [Related]
16. Reducing relapse in depressed outpatients with atypical features: a pilot study. Jarrett RB, Kraft D, Schaffer M, Witt-Browder A, Risser R, Atkins DH, Doyle J. Psychother Psychosom; 2000 Dec 15; 69(5):232-9. PubMed ID: 10965287 [Abstract] [Full Text] [Related]
17. Quality of life after response to acute-phase cognitive therapy for recurrent depression. Vittengl JR, Jha MK, Minhajuddin A, Thase ME, Jarrett RB. J Affect Disord; 2021 Jan 01; 278():218-225. PubMed ID: 32971314 [Abstract] [Full Text] [Related]
18. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I. Eur Neuropsychopharmacol; 2004 Dec 01; 14(6):457-70. PubMed ID: 15589385 [Abstract] [Full Text] [Related]